Shear Wave Sonoelastography in the Diagnosis and Management of the Masseter Muscles Disorders
NCT ID: NCT03844854
Last Updated: 2019-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
150 participants
INTERVENTIONAL
2019-04-20
2021-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The project aims to evaluate the usefulness of shear wave sonoelastography in the diagnosis and monitoring of the management of masseter muscles disorders in TMD.
The project will analyze shear wave sonoelastography to determine the pathological tone of masticatory muscles in TMD characterized by pain, abnormal jaw movements and frequent coexistence of headache, otolaryngological disorders, as well as increased tension and pain in the muscles of the neck and shoulder girdle. In the first stage, standardization of sonoelastography of masseter muscles on healthy subjects without TMD will be performed. Normal values of elasticity for various groups of patients as well as factors affecting the result of the study will be determined. Standardization will cover the methodology of the examination. The second stage will assess efficacy of this method in monitoring the treatment progress in patients with TMD diagnosed with the DC-TMD protocol. Standardized sonoelastography examinations and assessment of pain and oral health will be conducted in healthy subjects and in TMD patients at baseline and after 12 weeks of treatment with manual therapy and stabilization occlusal splint. As a result, it will be possible to compare sonoelastography changes in muscle structure in relation to regression of clinical symptoms in response to treatment and to compare sonoelastography results to currently used methods for assessment of TMD.
The need for reliable determining of the sonoelastography values for diagnosis of TMD exist. The hardness of muscles of the human body vary, but norms for masticatory muscles remain undetermined. Available reports are inconclusive. They do not provide a methodology and do not address factors such as age, sex, examination at rest and during jaw-clenching. The present project eliminates those limitations, and as a result, contemporary medicine will get the basis for introducing sonoelastography for the diagnosis and monitoring of masticatory muscles disorders in various groups of patients.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Correlation Between Changes of Shear Wave Elastography and Surface Electromyogram of the Masseter
NCT02425839
Effects of Radial Shock Wave Therapy in the Treatment of Temporomandibular Joint Syndrome.
NCT04477122
Masticatory Muscle Activity in Patients With Pain-related Temporomandibular Disorders
NCT04409067
Comparison of the Effectiveness of Three Different Treatment Methods in Myofascial Pain Patients
NCT03400462
Influence of Manual Therapy in Temporomandibular Joint Disorder
NCT02880774
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the project is to evaluate the usefulness of shear wave sonoelastography in the diagnosis and monitoring of the progress of treatment of masticatory muscles disorders. To date, few reports attempting to establish normal values have been published, but the available reports have significant limitations.
2. Research project methodology The study is divided into two stages. The aim of the first stage is the development of the sonoelastography methodology with precise determination of the positioning of the sonography head and the patient's condyles in temporomandibular joints as well as the determination of the normal range of masticatory muscle structure in the population of healthy subjects. This stage includes people without the history of TMD and any deviations from normal values according to DC-TMD protocol. Patients treated with drugs affecting masticatory muscles function as well as those with systemic diseases which affect muscle function (e.g., neurological and hormonal disorders, neoplastic disease), above 60 years of age, patients with mental disorders and not agreeing to participate in the study will be excluded.
Measurement of the masticatory muscle structure will be performed based on the shear wave sonoelastography (SWE) used in the noninvasive assessment of soft tissue hardness. In this method, share waves generated by pressure are detected by longitudinal ultrasonography waves which propagate in the tissues much faster than shear waves. The measurement reflects the quantitative measurement of tissue hardness expressed in kilopascals. Among its advantages are low dependence on the operator, high repeatability and the possibility of quantitative evaluation of tested parameters. The main disadvantage of this method is the fact that every organ has its unique characteristics and hence, normative values must be determined separately for each of them. Examination of masticatory muscles will be conducted by one experienced operator in the same conditions using the same head and the same device. During the examination, the patients will lie on the bed in a supine position. Both masseter muscles will be examined in jaw bite and rest positions.
The second stage concerning the evaluation of the sonoelastography in the monitoring of the efficacy of treatment. Patients with temporomandibular disorders classified as group II - Masticatory Muscle Disorders (DC-TMD). Exclusion criteria will include previous treatment for masticatory muscles disorders and clinical criteria used in the first stage. Control group will include patients without temporomandibular disorders. The treated group will undergo treatment for masticatory muscles disorders with manual therapy and stabilization occlusal splint. The assessment of severity of pain with Numerical Rating Scale and quality of life associated with oral health using standardized international questionnaire - the Oral Health Impact Profile-14 (OHIP-14) will be conducted at baseline and after 12 weeks of treatment. Masticatory muscle structure as measured with sonoelastography and the results of DC-TMD protocols will be compared in order to evaluate treatment efficacy.
3. Expected impact of the research project on the development of science The investigators expect that the investigator's study will have a large and multidirectional impact on the development of science and the health of society. Gaining reliable method of masticatory muscle structure measurement in the course of masticatory muscles disorders will facilitate the conduct of clinical research by delivering an objective method for comparison of results of treatment conducted in various centers with various methods. The project is also important for public health. Better diagnosis and monitoring of the treatment of this chronic disorder gives a chance for improving oral health care for the entire population. Among the additional values of the project is the interdisciplinarity which is based on the use of cutting-edge non-invasive diagnostic imaging method in oral medicine.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
The second stage is devoted to the assessment of the sonoelastography in the monitoring of the efficacy of treatment. The study group will undergo treatment of masticatory muscles disorders using manual therapy and stabilization occlusal splint. The assessment of severity of pain with Numerical Rating Scale (NRS) and quality of life associated with oral health using standardized international questionnaire will be conducted at baseline and after 12 weeks of treatment.
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Without intervention.
No interventions assigned to this group
Research Group
With providing stabilization occlusal splint and manual therapy.
Stabilization occlusal splint and manual therapy
Providing stabilization occlusal splint and manual therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Stabilization occlusal splint and manual therapy
Providing stabilization occlusal splint and manual therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Second stage: Patients with TMD without previous history of treatment
* Age between 18 and 60
Exclusion Criteria
* Not agreeing to participate in the study
* Age under 18
* Age over 60
* Terminal general diseases
* Severe mental disorders
* Neoplasm disease
* Neuromuscular disorders
* Severe hormonal disorders
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Science Centre, Poland
OTHER_GOV
Wroclaw Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Anna Olchowy
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mieszko Wieckiewicz, DMD MSc PhD
Role: STUDY_DIRECTOR
Department of Experimental Dentistry, Wroclaw Medical University, Poland
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Olchowy A, Seweryn P, Olchowy C, Wieckiewicz M. Assessment of the masseter stiffness in patients during conservative therapy for masticatory muscle disorders with shear wave elastography. BMC Musculoskelet Disord. 2022 May 11;23(1):439. doi: 10.1186/s12891-022-05392-9.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PREL.B160.18.007.
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.